Epilep CREpilep® contains Carbamazepine which is an iminodibenzyl derivative with anticonvulsant properties and its structure is related to the tricyclic antidepressants. Carbmazepine is indicated in all forms of epilepsy except myoclonic and absence seizures. It is also indicated in trigeminal..
Indication: Anxietyas well as panic disorder, with or without agoraphobia. Epilepsy and other seizure disorders. Alone or as an adjunct in the management of myoclonic and akinetic seizures and petit mal variant (Lennox-Gastaut syndrome). May also be of some value in patients with absence spells (pet..
Indication: Anxietyas well as panic disorder, with or without agoraphobia. Epilepsy and other seizure disorders. Alone or as an adjunct in the management of myoclonic and akinetic seizures and petit mal variant (Lennox-Gastaut syndrome). May also be of some value in patients with absence spells (pet..
Indication: Anxietyas well as panic disorder, with or without agoraphobia. Epilepsy and other seizure disorders. Alone or as an adjunct in the management of myoclonic and akinetic seizures and petit mal variant (Lennox-Gastaut syndrome). May also be of some value in patients with absence spells (pet..
Indication: Anxietyas well as panic disorder, with or without agoraphobia. Epilepsy and other seizure disorders. Alone or as an adjunct in the management of myoclonic and akinetic seizures and petit mal variant (Lennox-Gastaut syndrome). May also be of some value in patients with absence spells (pet..
Indication: EslicarTM (Eslicarbazepine acetate) is indicated as an add-on therapy for partial seizure with or without secondary generalization. Dosage & Administration:EslicarTM(Eslicarbazepine acetate) must be added to existing anticonvulsant therapy. The recommendedstarting dose is 400 mg once dai..